Risk of Cardiovascular and All-Cause Mortality in Individuals With Diabetes Mellitus, Impaired Fasting Glucose, and Impaired Glucose Tolerance: The Australian Diabetes, Obesity, and Lifestyle Study (AusDiab)

Barr, Elizabeth L.M.; Zimmet, Paul Z.; Welborn, Timothy A.; Jolley, Damien; Magliano, Dianna J.; Dunstan, David W.; Cameron, Adrian J.; Dwyer, Terry; Taylor, Hugh R.; Tonkin, Andrew M.; Wong, Tien Y.; McNeil, John; Shaw, Jonathan E.

doi:10.1161/circulationaha.106.685628

Cited by 719Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and ResearchDiabetes Treatment and Management

Risk of Cardiovascular and All-Cause Mortality in Individuals With Diabetes Mellitus, Impaired Fasting Glucose, and Impaired Glucose Tolerance: The Australian Diabetes, Obesity, and Lifestyle Study (AusDiab)

Barr, Elizabeth L.M., Zimmet, Paul Z., Welborn, Timothy A., Jolley, Damien, Magliano, Dianna J., Dunstan, David W., Cameron, Adrian J., Dwyer, Terry +5 more·2007·Circulation

DOI 10.1161/circulationaha.106.685628

Open this paper in CoChat — free account

Abstract

Background— Diabetes mellitus increases the risk of cardiovascular disease (CVD) and all-cause mortality. The relationship between milder elevations of blood glucose and mortality is less clear. This study investigated whether impaired fasting glucose and impaired glucose tolerance, as well as diabetes mellitus, increase the risk of all-cause and CVD mortality. Methods and Results— In 1999 to 2000, glucose tolerance status was determined in 10 428 participants of the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). After a median follow-up of 5.2 years, 298 deaths occurred (88 CVD deaths). Compared with those with normal glucose tolerance, the adjusted all-cause mortality hazard ratios (HRs) and 95% confidence intervals (CIs) for known diabetes mellitus and newly diagnosed diabetes mellitus were 2.3 (1.6 to 3.2) and 1.3 (0.9 to 2.0), respectively. The risk of death was also increased in those with impaired fasting glucose (HR 1.6, 95% CI 1.0 to 2.4) and impaired glucose tolerance (HR 1.5, 95% CI 1.1 to 2.0). Sixty-five percent of all those who died of CVD had known diabetes mellitus, newly diagnosed diabetes mellitus, impaired fasting glucose, or impaired glucose tolerance at baseline. Known diabetes mellitus (HR 2.6, 95% CI 1.4 to 4.7) and impaired fasting glucose (HR 2.5, 95% CI 1.2 to 5.1) were independent predictors for CVD mortality after adjustment for age, sex, and other traditional CVD risk factors, but impaired glucose tolerance was not (HR 1.2, 95% CI 0.7 to 2.2). Conclusions— This study emphasizes the strong association between abnormal glucose metabolism and mortality, and it suggests that this condition contributes to a large number of CVD deaths in the general population. CVD prevention may be warranted in people with all categories of abnormal glucose metabolism.

Integrity signals

Registry

Crossref · 10.1161/circulationaha.106.685628

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cross-sectional studies argue in favour of vascular risk effects of mild or moderate hyperglycaemia, as there is an excess prevalence of coronary disease in those with fasting or postload hyperglycaemia below the diabetic level.
“Cross-sectional studies argue in favour of vascular risk effects of mild or moderate hyperglycaemia as there is an excess prevalence of coronary disease in those with fasting or postload hyperglycaemia below the diabetic level.86,87”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [86]

Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000 · see citing works
Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial
Stamler, J., Vaccaro, O., Neaton, J. D., Wentworth, D., & The Multiple Risk Factor Intervention Trial Research Group (1993) · Diabetes Care · doi:10.2337/diacare.16.2.434 · Cited by 4,063 · see citing works
The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years
Coutinho, M., Gerstein, H. C., Wang, Y., & Yusuf, S. (1999) · Diabetes Care · doi:10.2337/diacare.22.2.233 · Cited by 1,685 · see citing works
Glucose Tolerance and Cardiovascular Mortality: Comparison of Fasting and 2-Hour Diagnostic Criteria
(2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.3.397 · Cited by 1,371 · see citing works
Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure
Okura, Y., Urban, L. H., Mahoney, D. W., Jacobsen, S. J., & Rodeheffer, R. J. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.04.005 · Cited by 1,237 · see citing works
Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.
Tominaga, M., Eguchi, H., Manaka, H., Igarashi, K., Kato, T., & Sekikawa, A. (1999) · Diabetes Care · doi:10.2337/diacare.22.6.920 · Cited by 1,165 · see citing works
Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention
Unwin, N., Shaw, J., Zimmet, P., & Alberti, K. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00835.x · Cited by 1,133 · see citing works
Self-citation
Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: A prospective study
Norhammar, A., Tenerz, Å., Nilsson, G., Hamsten, A., Efendíc, S., Rydén, L., & Malmberg, K. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09089-x · Cited by 1,112 · see citing works
The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study.
Dunstan, D., Zimmet, P., Welborn, T., de Courten, M., Cameron, A., Sicree, R., Dwyer, T., Colagiuri, S., Jolley, D., Knuiman, M., et al. (2002) · Diabetes Care · doi:10.2337/diacare.25.5.829 · Cited by 1,018 · see citing works
Self-citation
Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971–1993
Gu, K., Cowie, C. C., & Harris, M. I. (1998) · Diabetes Care · doi:10.2337/diacare.21.7.1138 · Cited by 881 · see citing works
Surveillance and ascertainment of cardiovascular events
Ives, D. G., Fitzpatrick, A. L., Bild, D. E., Psaty, B. M., Kuller, L. H., Crowley, P. M., Cruise, R. G., & Theroux, S. (1995) · Annals of Epidemiology · doi:10.1016/1047-2797(94)00093-9 · Cited by 688 · see citing works
Waist circumference, waist–hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults
Dalton, M., Cameron, A. J., Zimmet, P., Shaw, J. E., Jolley, D., Dunstan, D. W., & Welborn, T. A. (2003) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2003.01229.x · Cited by 666 · see citing works
Self-citation
The prevalence of abnormal glucose regulation in patients with coronary artery disease across EuropeThe Euro Heart Survey on diabetes and the heart
BARTNIK, M. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.07.027 · Cited by 617 · see citing works
High Blood Glucose Concentration Is a Risk Factor for Mortality in Middle-Aged Nondiabetic Men: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study
Balkau, B., Shipley, M. J., Jarrett, R. J., Pyörälà, K., Pyörälä, M., Forhan, A., & Eschwège, É. (1998) · Diabetes Care · doi:10.2337/diacare.21.3.360 · Cited by 597 · see citing works
Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?
The DECODE Study Group, & on behalf of the European Diabetes Epidemiology Group (2003) · Diabetes Care · doi:10.2337/diacare.26.3.688 · Cited by 516 · see citing works
Effects of Diabetes and Level of Glycemia on All-Cause and Cardiovascular Mortality: The San Antonio Heart Study
Wei, M., Gaskill, S. P., Haffner, S., & Stern, M. (1998) · Diabetes Care · doi:10.2337/diacare.21.7.1167 · Cited by 515 · see citing works
The Australian Diabetes, Obesity and Lifestyle Study (AusDiab)—methods and response rates
Dunstan, D. W., Zimmet, P., Welborn, T. A., Cameron, A. J., Shaw, J. E., de Courten, M., Jolley, D., & McCarty, D. J. (2002) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(02)00025-6 · Cited by 495 · see citing works
Self-citation
Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin
the DECODA Study Group, & Nakagami, T. (2004) · Diabetologia · doi:10.1007/s00125-004-1334-6 · Cited by 331 · see citing works
Validity of Self-Reported Stroke
Engstad, T. A., Bønaa, K. H., & Viitanen, M. H. (2000) · Stroke · doi:10.1161/01.str.31.7.1602 · Cited by 270 · see citing works
Comparison of Self-Report, Hospital Discharge Codes, and Adjudication of Cardiovascular Events in the Women's Health Initiative
Heckbert, S. R., Kooperberg, C. L., Safford, M. M., Psaty, B. M., Hsia, J. A., McTiernan, A., Gaziano, J. M., Frishman, W. H., & Curb, J. D. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh314 · Cited by 268 · see citing works
The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis
Gerstein, H. C., Pogue, J., Mann, J. F. E., Lonn, E., Dagenais, G. R., McQueen, M., Yusuf, S., & HOPE investigators (2005) · Diabetologia · doi:10.1007/s00125-005-1858-4 · Cited by 262 · see citing works
Subclinical States of Glucose Intolerance and Risk of Death in the U.S.
Saydah, S., Loria, C. M., Eberhardt, M. S., & Brancati, F. L. (2001) · Diabetes Care · doi:10.2337/diacare.24.3.447 · Cited by 237 · see citing works
Diabetes, Asymptomatic Hyperglycemia, and 22-Year Mortality in Black and White Men: The Chicago Heart Association Detection Project in Industry Study
Lowe, L. P., Liu, K., Greenland, P., Metzger, B. E., Dyer, A. R., & Stamler, J. (1997) · Diabetes Care · doi:10.2337/diacare.20.2.163 · Cited by 235 · see citing works
Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men.
Bjørnholt, J. V., Erikssen, G., Aaser, E., Sandvik, L., NITTER‐HAUGE, S., Jervell, J., Erikssen, J., & Thaulow, E. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.45 · Cited by 201 · see citing works
Abnormal Glucose Tolerance and the Risk of Cancer Death in the United States
Saydah, S. H. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg100 · Cited by 185 · see citing works
Relationship between diabetes and mortality: a population study using record linkage.
Morgan, C. L., Currie, C. J., & Peters, J. R. (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1103 · Cited by 182 · see citing works
Age and the Burden of Death Attributable to Diabetes in the United States
Saydah, S. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf111 · Cited by 173 · see citing works
Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program.
Rodríguez, B. L., Lau, N., Burchfiel, C. M., Abbott, R. D., Sharp, D. S., Yano, K., & Curb, J. D. (1999) · Diabetes Care · doi:10.2337/diacare.22.8.1262 · Cited by 171 · see citing works
Is there a glycemic threshold for mortality risk?
Balkau, B., Bertrais, S., Ducimetière, P., & Eschwège, É. (1999) · Diabetes Care · doi:10.2337/diacare.22.5.696 · Cited by 160 · see citing works
Untreated hypertension among Australian adults: the 1999–2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab)
Briganti, E. M., McNeil, J. J., Shaw, J. E., Zimmet, P., Chadban, S. J., Atkins, R. C., & Welborn, T. A. (2003) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2003.tb05471.x · Cited by 153 · see citing works
Self-citation
Accuracy of the Australian National Death Index: comparison with adjudicated fatal outcomes among Australian participants in the Long‐term Intervention with Pravastatin in Ischaemic Disease (LIPID) study
Magliano, D. J., Liew, D., Pater, H., Kirby, A. C., Hunt, D. U., Simes, J. R., Sundararajan, V., & Tonkin, A. M. (2003) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1467-842x.2003.tb00615.x · Cited by 134 · see citing works
Self-citation
Risk factor management in diabetic and non-diabetic patients with coronary heart disease. Findings from the EUROASPIRE I AND II surveys
Groups*, T. E. I. A. I., Pyörälà, K., Lehto, S., Bacquer, D. D., SUTTER, J. D., Sans, S., Keil, U., Wood, D., & Backer, G. D. (2004) · Diabetologia · doi:10.1007/s00125-004-1438-z · Cited by 118 · see citing works
POST-LOAD PLASMA GLUCOSE AND CANCER MORTALITY IN MIDDLE-AGED MEN AND WOMEN
LEVINE, W., Dyer, A. R., Shekelle, R. B., Schoenberger, J. A., & Stamler, J. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115495 · Cited by 103 · see citing works
Diabetes in the New Millennium
Turtle, J. R., Kaneko, T., & Osato, S. (1999) · Medical Entomology and Zoology · Cited by 68 · see citing works

Flagged first, then by citations

Sorted by citations

Prediabetes: a high-risk state for diabetes development
Tabák, A. G., Herder, C., Rathmann, W., Brunner, E. J., & Kivimäki, M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60283-9 · Cited by 2,958 · see citing works
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document
Mancia, G., Laurent, S., Agabiti-Rosei, E., Ambrosioni, E., Burnier, M., Caulfield, M. J., Cifkova, R., Clément, D., Coca, A., Dominiczak, A., et al. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e328333146d · Cited by 1,643 · see citing works
Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
Teede, H., Deeks, A., & Moran, L. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-41 · Cited by 1,565 · see citing works
Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis
Huang, Y., Cai, X., Mai, W., Li, M., & Hu, Y. (2016) · BMJ · doi:10.1136/bmj.i5953 · Cited by 1,012 · see citing works
Television Viewing Time and Mortality: The Australian Diabetes, Obesity and Lifestyle Study (AusDiab)
Dunstan, D. W., Barr, E. L. M., Healy, G. N., Salmon, J., Shaw, J. E., Balkau, B., Magliano, D. J., Cameron, A. J., Zimmet, P. Z., & Owen, N. (2010) · Circulation · doi:10.1161/circulationaha.109.894824 · Cited by 825 · see citing works
Self-citation
A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk
Bouatia-Naji, N., Bonnefond, A., Cavalcanti-Proença, C., Sparsø, T., Holmkvist, J., Marchand, M., Delplanque, J., Lobbens, S., Rocheleau, G., Durand, E., et al. (2009) · Nature Genetics · doi:10.1038/ng.277 · Cited by 611 · see citing works
Prediabetes diagnosis and treatment: A review
Bansal, N. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i2.296 · Cited by 579 · see citing works
Thyroid dysfunction and diabetes mellitus: two closely associated disorders
Biondi, B., Kahaly, G. J., & Robertson, R. P. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00163 · Cited by 598 · see citing works
Lifestyle Interventions for Patients With and at Risk for Type 2 Diabetes: A Systematic Review and Meta-analysis
Schellenberg, E. S., Dryden, D. M., Vandermeer, B., Ha, C., & Korownyk, C. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-8-201310150-00007 · Cited by 520 · see citing works
Pre-Diabetes and the Risk for Cardiovascular Disease
Ford, E. S., Zhao, G., & Li, C. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.10.060 · Cited by 480 · see citing works
A new look at screening and diagnosing diabetes mellitus
Saudek, C. D., Herman, W. H., Sacks, D. B., Bergenstal, R. M., Edelman, D., & Davidson, M. B. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2174 · Cited by 432 · see citing works
Prevalence of Pre-Diabetes and Its Association With Clustering of Cardiometabolic Risk Factors and Hyperinsulinemia Among U.S. Adolescents
Li, C., Ford, E. S., Zhao, G., & Mokdad, A. H. (2009) · Diabetes Care · doi:10.2337/dc08-1128 · Cited by 340 · see citing works
“Individuals with impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT) are at increased risk for diabetes and cardiovascular-related death (1,2).”
Background
Dietary salt intake and mortality in patients with type 2 diabetes
Ekinci, E. I., Clarke, S., Thomas, M. C., Moran, J. L., Cheong, K., MacIsaac, R. J., & Jerums, G. (2011) · Diabetes Care · doi:10.2337/dc10-1723 · Cited by 309 · see citing works
Resistance Training in the Treatment of the Metabolic Syndrome: A Systematic Review and Meta-Analysis of the Effect of Resistance Training on Metabolic Clustering in Patients with Abnormal Glucose Metabolism
Strasser, B., Siebert, U., & Schobersberger, W. (2010) · Sports Medicine · doi:10.2165/11531380-000000000-00000 · Cited by 258 · see citing works
Prediabetes and Lifestyle Modification: Time to Prevent a Preventable Disease
Tuso, P. (2014) · The Permanente Journal · doi:10.7812/tpp/14-002 · Cited by 252 · see citing works
Postprandial Hyperglycemia and Glycemic Variability
Standl, E., Schnell, O., & Ceriello, A. (2011) · Diabetes Care · doi:10.2337/dc11-s206 · Cited by 183 · see citing works
A review of potential metabolic etiologies of the observed association between red meat consumption and development of type 2 diabetes mellitus
Kim, Y., Keogh, J., & Clifton, P. (2015) · Metabolism · doi:10.1016/j.metabol.2015.03.008 · Cited by 181 · see citing works
Distinguishing Hyperglycemic Changes by Set7 in Vascular Endothelial Cells
Okabe, J., Orlowski, C., Balcerczyk, A., Tikellis, C., Thomas, M. C., Cooper, M. E., & El-Osta, A. (2012) · Circulation Research · doi:10.1161/circresaha.112.266171 · Cited by 180 · see citing works
Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review
Sarwar, N., Aspelund, T., Eiriksdottir, G., Gobin, R., Seshasai, S. R. K., Forouhi, N. G., Sigurdsson, G., Danesh, J., & Gudnason, V. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000278 · Cited by 175 · see citing works
Effects of a mindfulness‐based weight loss intervention in adults with obesity: A randomized clinical trial
Daubenmier, J., Moran, P. J., Kristeller, J., Acree, M., Bacchetti, P., Kemeny, M. E., Dallman, M., Lustig, R. H., Grunfeld, C., Nixon, D. F., et al. (2016) · Obesity · doi:10.1002/oby.21396 · Cited by 151 · see citing works
Prevention of diabetes and reduction in major cardiovascular events in studies of subjects with prediabetes: meta-analysis of randomised controlled clinical trials
Hopper, I., Billah, B., Skiba, M., & Krum, H. (2011) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/1741826711421687 · Cited by 149 · see citing works
Heart rate-corrected QT interval is an independent predictor of all-cause and cardiovascular mortality in individuals with type 2 diabetes: the diabetes heart study
Cox, A. J., Azeem, A., Yeboah, J., Soliman, E. Z., Aggarwal, S. R., Bertoni, A. G., Carr, J. J., Freedman, B. I., Herrington, D. M., & Bowden, D. W. (2014) · Diabetes Care · doi:10.2337/dc13-1257 · Cited by 96 · see citing works
Effects of Exenatide vs. Metformin on endothelial function in obese patients with pre-diabetes: a randomized trial
Kelly, A. S., Bergenstal, R. M., Gonzalez-Campoy, J., Katz, H., & Bank, A. J. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-64 · Cited by 98 · see citing works
A position statement on screening and management of prediabetes in adults in primary care in Australia
Bell, K., Shaw, J. E., Maple-Brown, L., Ferris, W., Gray, S., Murfet, G., Flavel, R., Maynard, B., Ryrie, H., Pritchard, B., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108188 · Cited by 64 · see citing works
Self-citation
The impact of food order on postprandial glycaemic excursions in prediabetes
Shukla, A. P., Dickison, M., Coughlin, N., Karan, A., Mauer, E., Truong, W., Casper, A., Emiliano, A. B., Kumar, R. B., Saunders, K. H., et al. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13503 · Cited by 66 · see citing works
Metformin does not affect clinically relevant outcomes in patients with idiopathic pulmonary fibrosis
Spagnolo, P., Kreuter, M., Maher, T. M., Wuyts, W., Bonella, F., Corte, T. J., Kopf, S., Weycker, D., Kirchgaessler, K.-U., & Ryerson, C. J. (2018) · Respiration · doi:10.1159/000489668 · Cited by 61 · see citing works
Common mental disorders associated with 2-year diabetes incidence: The Netherlands Study of Depression and Anxiety (NESDA)
Atlantis, E., Vogelzangs, N., Cashman, K., & Penninx, B. J. W. H. (2012) · Journal of Affective Disorders · doi:10.1016/s0165-0327(12)70006-x · Cited by 51 · see citing works
Skeletal muscle as a treatment target for older adults with diabetes mellitus: The importance of a multimodal intervention based on functional category
Omura, T., & Araki, A. (2022) · Geriatrics & Gerontology International · doi:10.1111/ggi.14339 · Cited by 47 · see citing works
The clustering of Cardiovascular, Renal, Adipo-Metabolic Eye and Liver disease with type 2 diabetes
Thomas, M. C. (2022) · Metabolism · doi:10.1016/j.metabol.2021.154961 · Cited by 41 · see citing works
Prediabetes is associated with an increased risk of testosterone deficiency, independent of obesity and metabolic syndrome
Ho, C.-H., Yu, H.-J., Wang, C.-Y., Jaw, F.-S., Hsieh, J.-T., Liao, W.-C., Pu, Y.-S., & Liu, S.-P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074173 · Cited by 40 · see citing works
Serum 1,5-anhydroglucitol level as a screening tool for diabetes mellitus in a community-based population at high risk of diabetes
Wang, Y., Yuan, Y., Zhang, Y., Lei, C., Zhou, Y., He, J., & Sun, Z. (2017) · Acta Diabetologica · doi:10.1007/s00592-016-0944-z · Cited by 37 · see citing works
Impact of post-challenge hyperglycemia on clinical outcomes in japanese patients with stable angina undergoing percutaneous coronary intervention
Kuramitsu, S., Yokoi, H., Domei, T., Nomura, A., Watanabe, H., Yamaji, K., Soga, Y., Arita, T., Kondo, K., Shirai, S., et al. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-74 · Cited by 26 · see citing works
A Web-Based Computer-Tailored Program to Improve Treatment Adherence in Patients With Type 2 Diabetes: Randomized Controlled Trial
Vluggen, S., Candel, M., Hoving, C., Schaper, N. C., & de Vries, H. (2021) · Journal of Medical Internet Research · doi:10.2196/18524 · Cited by 26 · see citing works
A cost-effectiveness analysis of a telephone-linked care intervention for individuals with Type 2 diabetes
Gordon, L. G., Bird, D., Oldenburg, B., Friedman, R. H., Russell, A. W., & Scuffham, P. A. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.12.032 · Cited by 23 · see citing works
Impaired fasting glucose and major adverse cardiovascular events by hypertension and dyslipidemia status: the Golestan cohort study
Hashemi Madani, N., Ismail-Beigi, F., Poustchi, H., Nalini, M., Sepanlou, S. G., Malek, M., Abbasi, M. A., Khajavi, A., Khamseh, M. E., & Malekzadeh, R. (2020) · BMC Cardiovascular Disorders · doi:10.1186/s12872-020-01390-8 · Cited by 22 · see citing works
Evaluation of lorcaserin on progression of prediabetes to type 2 diabetes and reversion to euglycemia
Nesto, R., Fain, R., Li, Y., & Shanahan, W. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2016.1178590 · Cited by 20 · see citing works

Progression to and Prevention of Diabetes: Disparity of Impaired Fasting Glucose and Impaired Glucose Tolerance - Review Article
(2020) · Journal of the Medical Association of Thailand · doi:10.35755/jmedassocthai.2020.08.11222
The concept of impaired fasting glucose and impaired glucose tolerance and their different profiles
Ju-min, L. (2006)
Evidence From a Systematic Review and Meta-Analysis: Classical Impaired Glucose Tolerance Should Be Divided Into Subgroups of Isolated Impaired Glucose Tolerance and Impaired Glucose Tolerance Combined With Impaired Fasting Glucose, According to the Risk of Progression to Diabetes
Liu, Y., Li, J., Wu, Y., Zhang, H., Lv, Q., Zhang, Y., Zheng, X., & Tong, N. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.835460 · Cited by 19 · see citing works
Prevalence of Pre-Diabetes across Ethnicities: A Review of Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT) for Classification of Dysglycaemia
Yip, W., Sequeira, I., Plank, L., & Poppitt, S. (2017) · Nutrients · doi:10.3390/nu9111273 · Cited by 177 · see citing works
0225: Impaired glucose tolerance and impared fasting glucose in patients with essential hypertension
Zhuravlyova, L., & Yankevich, O. O. (2016) · Archives of Cardiovascular Diseases Supplements · doi:10.1016/s1878-6480(16)30191-4

Authors: Barr, E. L. M., Zimmet, P. Z., Welborn, T. A., Jolley, D., Magliano, D. J., Dunstan, D. W., Cameron, A. J., Dwyer, T., Taylor, H. R., Tonkin, A. M., Wong, T. Y., McNeil, J., & Shaw, J. E.
Affiliations: Royal Children's Hospital (AU)
From the International Diabetes Institute (E.L.M.B., P.Z.Z., D.J.M., D.W.D., A.J.C., J.E.S.), Caulfield, Victoria, Australia; Department of Medicine (T.A.W.), University of Western Australia, Nedlands, Western Australia; Monash Institute of Health Services Research (D.J.), Clayton, Victoria, Australia; Murdoch Children’s Research Institute (T.D.), Royal Children’s Hospital, Prahran, Victoria, Australia; Centre for Eye Research Australia (H.R.T., T.Y.W.), University of Melbourne, East Melbourne,...
ORCID: Barr, Elizabeth L.M.
Zimmet, Paul Z.
Welborn, Timothy A.
Magliano, Dianna J.
Dunstan, David W.
Cameron, Adrian J.
Taylor, Hugh R.
Tonkin, Andrew M.
Wong, Tien Y.
McNeil, John
Shaw, Jonathan E.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2007-07-10
Volume: 116
Issue: 2
Pages: 151-157
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/circulationaha.106.685628
OpenAlex: W2109124852
Cited by: 719
References: 34
Citations by year: 2026: 10 · 2025: 14 · 2024: 21 · 2023: 33 · 2022: 35 · 2021: 20 · 2020: 28 · 2019: 35 · 2018: 33 · 2017: 36 · 2016: 59 · 2015: 61 · 2014: 50 · 2013: 42 · 2012: 56
FWCI: 29.95
Type: journal article
Language: en
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Deakin Research Online (Deakin University) (submittedVersion)
Funders: Novo Nordisk
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords: diabetes mellitus, impaired fasting glucose, impaired glucose tolerance, cardiovascular mortality, all-cause mortality, abnormal glucose metabolism, newly diagnosed diabetes, cardiovascular disease prevention, AusDiab
MeSH terms: Aged, Australia, Blood Glucose, Cardiovascular Diseases, Diabetic Angiopathies, Female, Follow-Up Studies, Glucose Tolerance Test, Health Surveys, Humans, Life Style, Male, Middle Aged, Obesity, Risk Factors, Glucose Intolerance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Risk of Cardiovascular and All-Cause Mortality in Individuals With Diabetes Mellitus, Impaired Fasting Glucose, and Impaired Glucose Tolerance: The Australian Diabetes, Obesity, and Lifestyle Study (AusDiab)

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cites

Cited by

Related

Record

About these checks